📖

RNA Metabolism in Alzheimer's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-rna-metabolism-alzheimer

Related Entities

mechanisms-rna-metabolism-alzheimers-disease

Metadata

slug	mechanisms-rna-metabolism-alzheimers-disease
entity_type	mechanism
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (633)

related🧪HSP90-Tau Disaggregation Complex Enhancement80%

related🧪VCP-Mediated Autophagy Enhancement80%

related🧪LRP1-Dependent Tau Uptake Disruption80%

related🧪Extracellular Vesicle Biogenesis Modulation80%

related🧪Synaptic Vesicle Tau Capture Inhibition80%

related🧪TREM2-mediated microglial tau clearance enhancement80%

related🧪Trans-Synaptic Adhesion Molecule Modulation80%

related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia80%

related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation80%

related🧪Complement C1QA Spatial Gradient in Cortical Layers80%

related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation80%

related🧪APOE Isoform Expression Across Glial Subtypes80%

related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro80%

related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli80%

related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK80%

related🧪Prefrontal sensory gating circuit restoration via PV interne80%

related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna80%

related🧪Gamma entrainment therapy to restore hippocampal-cortical sy80%

see_also📖Alzheimer's Disease Biomarkers80%

see_also📖ASL Perfusion Biomarkers for Alzheimer's Disease80%

see_also📖Digital Biomarkers for Alzheimer's Disease80%

see_also📖Dried Blood Spot Biomarker Test for Alzheimer's Disease80%

see_also📖DTI Biomarkers for Alzheimer's Disease80%

see_also📖EEG Biomarkers for Alzheimer's Disease80%

see_also📖Eye-Tracking Digital Markers in Alzheimer's Disease80%

see_also📖Gait Biomarkers for Alzheimer's Disease80%

see_also📖GFAP in Alzheimer's Disease80%

see_also📖Inflammatory Biomarkers in Alzheimer's Disease80%

see_also📖Neurogranin - Alzheimer's Disease Biomarker80%

see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease80%

see_also📖Ocular Fluid Biomarkers for Alzheimer's Disease80%

see_also📖Olfactory Biomarkers for Alzheimer's Disease80%

see_also📖Plasma Phospho-Tau Ratio Diagnostic Panel for Alzheimer'80%

see_also📖Salivary Biomarkers for Alzheimer's Disease80%

see_also📖Sleep Biomarkers for Alzheimer's Disease80%

see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease80%

see_also📖Synaptic Biomarkers for Alzheimer's Disease80%

see_also📖Tear Film Biomarkers in Alzheimer's Disease80%

see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers80%

see_also📖Diffuse Amyloid Deposits in Alzheimer's Disease80%

see_also📖ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)80%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh80%

see_also📖ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05680%

see_also📖BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer80%

see_also📖BMS-986368 Phase 2 - Agitation in Alzheimer's Disease80%

see_also📖BMS-986446 Phase 2 Trial for Early Alzheimer's Disease80%

see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058280%

see_also📖Centella asiatica Phase 1 Trial for Alzheimer's Disease80%

see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06780%

see_also📖Escitalopram for Agitation in Alzheimer's Disease (NCT080%

see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer80%

see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di80%

see_also📖Fasudil for Early Alzheimer's Disease (FEAD) - NCT0636280%

see_also📖[F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disea80%

see_also📖Foralumab Phase 2 Trial for Alzheimer's Disease80%

see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0680%

see_also📖Guanfacine NorAD - Phase 3 Trial for Alzheimer's Diseas80%

see_also📖IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543680%

see_also📖ITI-1284 for Alzheimer's Disease Psychosis (NCT0654083380%

see_also📖KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's D80%

see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise80%

see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 80%

see_also📖NCT03875638 - Levetiracetam for Alzheimer's Disease80%

see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime80%

see_also📖LHP588: P. gingivalis Targeting for Alzheimer's Disease80%

see_also📖MAR Polypill for Alzheimer's Disease (NCT06597058)80%

see_also📖Masupirdine for Alzheimer's Disease Agitation80%

see_also📖Masupirdine for Agitation in Alzheimer's Disease (NCT0580%

see_also📖MK-2214 for Early Alzheimer's Disease80%

see_also📖Nabilone for Agitation in Alzheimer's Disease (NCT0451680%

see_also📖NAB-IT: Nabilone for Agitation in Alzheimer's Disease80%

see_also📖TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical 80%

see_also📖GV1001 for Moderate to Severe Alzheimer's Disease (NCT080%

see_also📖Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)80%

see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di80%

see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 80%

see_also📖CBD (Cannabidiol) for Alzheimer's Disease Agitation - N80%

see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0680%

see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC80%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI80%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St80%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451680%

see_also📖Master Screening Study to Determine Individuals With Potenti80%

see_also📖NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)80%

see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer80%

see_also📖DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer'80%

see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial80%

see_also📖NCT06582706: Nicotinic Acid for Alzheimer's Disease80%

see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A80%

see_also📖NRTIs for Alzheimer's Disease: Targeting Type-I Interfe80%

see_also📖ONO-2020 for Alzheimer's Disease (NCT06881836)80%

see_also📖NCT06803823 - ONO-2020 for Agitation in Alzheimer's Dis80%

see_also📖Ozanimod for Alzheimer's Disease (NCT06862960)80%

see_also📖Piromelatine 20 mg for Mild Dementia Due to Alzheimer's80%

see_also📖PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Dise80%

see_also📖Probiotics in Mild Alzheimer's Disease (NCT06181513)80%

see_also📖Recombinant Human Serum Albumin for Alzheimer's Disease80%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime80%

see_also📖Senicapoc Alzheimer's Disease Trial - NCT0480424180%

see_also📖SHR-1707 for Alzheimer's Disease (NCT06199037)80%

see_also📖Siponimod for Alzheimer's Disease (NCT06639282)80%

see_also📖SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheime80%

see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention80%

see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'80%

see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial80%

see_also📖Alzheimer's Disease Mechanism Index80%

see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease80%

see_also📖APOE4 and Alzheimer's Disease Risk80%

see_also📖CD33 Siglec Receptor Dysfunction Alzheimer's Disease Ca80%

see_also📖Cholinergic System Degeneration in Alzheimer's Disease80%

see_also📖EEG Microstates in Alzheimer's Disease80%

see_also📖Endolysosomal Pathway in Alzheimer's Disease80%

see_also📖Geniposide for Alzheimer's disease - immune biomarker t80%

see_also📖Glymphatic System in Alzheimer's Disease80%

see_also📖Locus Coeruleus Degeneration in Alzheimer's Disease80%

see_also📖Metal Ion Homeostasis in Alzheimer's Disease80%

see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa80%

see_also📖Neuroinflammation in Alzheimer's Disease80%

see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease80%

see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ80%

see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease80%

see_also📖Sex-Specific Mechanisms in Alzheimer's Disease80%

see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease80%

see_also📖Sporadic Alzheimer's Disease Pathway80%

see_also📖Synaptic Loss in Alzheimer's Disease Pathway80%

see_also📖Tau Kinase-Phosphatase Balance in Alzheimer's Disease80%

see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%

see_also📖Ubiquitin-Proteasome System Dysfunction in Alzheimer's 80%

see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's80%

mentions🔬RNA binding protein dysregulation across ALS FTD AD75%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD75%

related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia72%

related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation72%

related🧪Complement C1QA Spatial Gradient in Cortical Layers72%

related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation72%

related🧪APOE Isoform Expression Across Glial Subtypes72%

related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro72%

related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli72%

related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK72%

mentions🧫Microarray and single-cell RNA analysis of lipid metabolism 70%

mentions🧫dilncRNA-mediated molecular crowding and phase separation70%

mentions🧫Competing endogenous RNA (ceRNA) network construction70%

mentions🧫Factor depletion effects on DDR focus formation in vivo70%

mentions🧫Activity-dependent PGC-1α transcriptional program analysis70%

mentions🧫scRNA-seq analysis of human atherosclerotic plaques70%

mentions🧫Multi-omics analysis of NP137 mechanism in patient biopsies70%

mentions🧫Sevoflurane-induced neurotoxicity (SIN) model in rats70%

mentions🧫PGC-1α expression analysis during PV+ interneuron developmen70%

mentions🧫Multi-omics analysis of myricanol effects on gene expression70%

mentions🧫G3BP1-mediated stress granule assembly via liquid-liquid pha70%

mentions🧫Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m70%

mentions🧫LINC00599-MYH9 liquid-liquid phase separation analysis70%

mentions🧫Single-cell RNA sequencing analysis of human atherosclerotic70%

mentions🧫NPM1 knockout tumor progression study in syngeneic mice70%

mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%

mentions🧫dilncRNA-mediated molecular crowding and phase separation70%

mentions🧫Single-cell RNA-seq analysis of mouse testes with gonadal de70%

mentions🧫Gestational haloperidol exposure effects on hippocampal gene70%

mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%

mentions🧫Machine learning-based identification of C1Q hub genes70%

mentions🧫Single-cell RNA sequencing of microglial states in AD hippoc70%

mentions🧫Single-cell RNA sequencing of EMT states in SCC70%

mentions🧫BDEV injection and recipient microglial transcriptome analys70%

mentions🧫Sevoflurane-induced neurotoxicity (SIN) rat model70%

mentions🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter70%

mentions🧫Single-cell RNA sequencing analysis of microglial heterogene70%

mentions🧫Single-nucleus RNA-seq integration analysis70%

mentions🧫Small RNA profiling of neonatal astrocyte EVs and microglia 70%

mentions🧫ZNF263-mediated LINC00599 transcriptional regulation70%

mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%

mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi70%

mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%

mentions🧫Proposed experiment from debate on Microglia activate astroc70%

mentions🧫s:** - Test whether HCN1 knockout specifically in EC layer I70%

mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%

mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%

mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%

mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%

mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%

mentions🧫s:** - Compare uptake with/without magnetic particles using 70%

mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%

mentions🧫Proposed experiment from debate on Perivascular spaces and g70%

mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr70%

mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%

mentions🧫s:** - Dose-response studies showing therapeutic window with70%

mentions🧫Proposed experiment from debate on Senolytics targeting p16/70%

mentions🧫Proposed experiment from debate on Microglia activate astroc70%

mentions🧫FLS Stimulation and Transcriptomic Analysis70%

mentions🧫Single-cell RNA sequencing of mouse brains70%

mentions🧫Netrin-1 and UNC5B knockdown effects on EMT in vitro70%

mentions🧫LINC00599 role in human PASMC proliferation70%

mentions🧫LINC00599 expression analysis in hypoxic PH models70%

mentions🧫DDR factor depletion and focus formation analysis70%

mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera70%

mentions🧫AAV-LRRK2 IND-Enabling Study Design70%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%

mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio70%

mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker70%

mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model70%

mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk70%

mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%

mentions🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?70%

mentions🧫Animal Model Comparison for Neurodegenerative Disease Therap70%

mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%

mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%

mentions🧫ApoE4 Function in Alzheimer's Disease70%

mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%

mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 70%

mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%

mentions🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka70%

mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%

mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study70%

mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%

mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise70%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP70%

mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa70%

mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%

mentions🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 70%

mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%

mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen70%

mentions🧫Epigenetic Dysregulation in Huntington's Disease — Ther70%

mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%

mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa70%

mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%

mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%

mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%

mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio70%

mentions🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas70%

mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P70%

mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%

mentions🧫Microglial Contributions to Huntington's Disease Pathog70%

mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise70%

mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%

mentions🧫Parkinson's Disease Subtype Classification — Precision 70%

mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic70%

mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%

mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD70%

mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise70%

mentions🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel70%

mentions🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec70%

mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D70%

mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di70%

mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki70%

mentions🧫TDP-43 PET Ligand Development for FTD and ALS70%

mentions🧫Experiment Validation: In vitro ThT Assay70%

mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%

mentions🧫Tau ASO Therapy70%

mentions🧫Microglial TREM2 Agonist In Vivo Efficacy70%

mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%

mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

mentions🧪Phase-Separated Organelle Targeting69%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna69%

mentions🧪Stress Granule Phase Separation Modulators69%

mentions🧪Vagal Afferent Microbial Signal Modulation68%

related🔬RNA binding protein dysregulation across ALS FTD AD67%

related🔬RNA binding protein dysregulation across ALS FTD and AD67%

mentions🧪RNA Granule Nucleation Site Modulation67%

related🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste65%

related🧪Nutrient-Sensing Epigenetic Circuit Reactivation65%

mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors64%

mentions🧪Vocal Cord Neuroplasticity Stimulation63%

related🧫Microarray and single-cell RNA analysis of lipid metabolism 63%

related🧫dilncRNA-mediated molecular crowding and phase separation63%

related🧫Competing endogenous RNA (ceRNA) network construction63%

related🧫Factor depletion effects on DDR focus formation in vivo63%

related🧫Activity-dependent PGC-1α transcriptional program analysis63%

related🧫scRNA-seq analysis of human atherosclerotic plaques63%

related🧫Multi-omics analysis of NP137 mechanism in patient biopsies63%

related🧫Sevoflurane-induced neurotoxicity (SIN) model in rats63%

related🧫PGC-1α expression analysis during PV+ interneuron developmen63%

related🧫Multi-omics analysis of myricanol effects on gene expression63%

related🧫G3BP1-mediated stress granule assembly via liquid-liquid pha63%

related🧫Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m63%

related🧫LINC00599-MYH9 liquid-liquid phase separation analysis63%

related🧫Single-cell RNA sequencing analysis of human atherosclerotic63%

related🧫NPM1 knockout tumor progression study in syngeneic mice63%

related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%

related🧫dilncRNA-mediated molecular crowding and phase separation63%

related🧫Single-cell RNA-seq analysis of mouse testes with gonadal de63%

related🧫Gestational haloperidol exposure effects on hippocampal gene63%

related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%

related🧫Machine learning-based identification of C1Q hub genes63%

related🧫Single-cell RNA sequencing of microglial states in AD hippoc63%

related🧫Single-cell RNA sequencing of EMT states in SCC63%

related🧫BDEV injection and recipient microglial transcriptome analys63%

related🧫Sevoflurane-induced neurotoxicity (SIN) rat model63%

related🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter63%

related🧫Single-cell RNA sequencing analysis of microglial heterogene63%

related🧫Single-nucleus RNA-seq integration analysis63%

related🧫Small RNA profiling of neonatal astrocyte EVs and microglia 63%

related🧫ZNF263-mediated LINC00599 transcriptional regulation63%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%

related🧫s:** - Biochemical binding assays measuring PROTAC selectivi63%

related🧫Proposed experiment from debate on Epigenetic clocks and bio63%

related🧫Proposed experiment from debate on Microglia activate astroc63%

related🧫s:** - Test whether HCN1 knockout specifically in EC layer I63%

related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%

related🧫Proposed experiment from debate on Epigenetic clocks and bio63%

related🧫s:** - Temporal analysis showing mitochondrial defects prece63%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%

related🧫s:** - Compare uptake with/without magnetic particles using 63%

related🧫Proposed experiment from debate on Mitochondrial transfer be63%

related🧫Proposed experiment from debate on Perivascular spaces and g63%

related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr63%

related🧫Proposed experiment from debate on Mitochondrial transfer be63%

related🧫s:** - Dose-response studies showing therapeutic window with63%

related🧫Proposed experiment from debate on Senolytics targeting p16/63%

related🧫Proposed experiment from debate on Microglia activate astroc63%

related🧫FLS Stimulation and Transcriptomic Analysis63%

related🧫Single-cell RNA sequencing of mouse brains63%

related🧫Netrin-1 and UNC5B knockdown effects on EMT in vitro63%

related🧫LINC00599 role in human PASMC proliferation63%

related🧫LINC00599 expression analysis in hypoxic PH models63%

related🧫DDR factor depletion and focus formation analysis63%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera63%

related🧫AAV-LRRK2 IND-Enabling Study Design63%

related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau63%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio63%

related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker63%

related🧫ALS Regional Onset and Spread: Network-Level Staging Model63%

related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk63%

related🧫Animal Model Comparison for Neurodegenerative Disease Therap63%

related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%

related🧫ApoE4 Function in Alzheimer's Disease63%

related🧫Autophagy Enhancement Drug Screening for Neurodegeneration63%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 63%

related🧫Blood-Based Biomarker Panel for Early AD Detection63%

related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka63%

related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT63%

related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study63%

related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise63%

related🧫CRISPR Gene Correction Approaches for CBS/PSP63%

related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa63%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i63%

related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 63%

related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%

related🧫Environmental Exposure Causal Attribution in ALS — Experimen63%

related🧫Epigenetic Dysregulation in Huntington's Disease — Ther63%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise63%

related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa63%

related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M63%

related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud63%

related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%

related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio63%

related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas63%

related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P63%

related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%

related🧫Microglial Contributions to Huntington's Disease Pathog63%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise63%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#63%

related🧫Parkinson's Disease Subtype Classification — Precision 63%

related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic63%

related🧫Progranulin Replacement Therapy for FTD — Vector Development63%

related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD63%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise63%

related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel63%

related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec63%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D63%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di63%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki63%

related🧫TDP-43 PET Ligand Development for FTD and ALS63%

related🧫Experiment Validation: In vitro ThT Assay63%

related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an63%

related🧫Tau ASO Therapy63%

related🧫Microglial TREM2 Agonist In Vivo Efficacy63%

related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia63%

related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 63%

related🧪Phase-Separated Organelle Targeting62%

related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna62%

related🧪Stress Granule Phase Separation Modulators62%

related🧪Vagal Afferent Microbial Signal Modulation61%

related🧪RNA Granule Nucleation Site Modulation60%

mentions🔬What are the mechanisms underlying rna binding protein dysre60%

related🧫s:** - Test whether HCN1 knockout specifically in EC layer I60%

related🧫Proposed experiment from debate on Synaptic pruning by micro60%

related🧫Brain Connectivity-Targeted tACS Trial in Early AD60%

related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%

related🧫4R-Tau Targeting Therapies for PSP and CBS60%

related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi60%

related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau60%

related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti60%

related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?60%

related🧫Animal Model Comparison for Neurodegenerative Disease Therap60%

related🧫Anti-Tau Immunotherapy Dosing Optimization60%

related🧫ApoE4 Function in Alzheimer's Disease60%

related🧫Experiment: Autoimmune Hypothesis Testing in AD60%

related🧫Autophagy Enhancement Drug Screening for Neurodegeneration60%

related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#60%

related🧫Blood-Based Biomarker Panel for Early AD Detection60%

related🧫tACS Connectivity Trial in Early Alzheimer's60%

related🧫Brain Connectivity-Targeted tACS Trial in Early AD60%

related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%

related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M60%

related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera60%

related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera60%

related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa60%

related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation60%

related🧫Gap Junction Dysfunction Validation in Parkinson's Dise60%

related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas60%

related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise60%

related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech60%

related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr60%

related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis60%

related🧫Mixed Pathology Effects on Parkinson's Disease Progress60%

related🧫Neural Stem Cell Therapy for Alzheimer's Disease60%

related🧫Normal Aging to Alzheimer's Disease Transition Trigger 60%

related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%

related🧫Prion Strain Diversity and Selective Vulnerability60%

related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%

related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#60%

related🧫Sex Differences in Alzheimer's Disease — mechanisms and60%

related🧫Sleep Disruption and Alzheimer's Disease — mechanism an60%

related🧫Traumatic Brain Injury and Alzheimer's Disease Relation60%

related🧫Experiment Validation: In vitro ThT Assay60%

related🧫Tau ASO Therapy60%

related🧫Microglial TREM2 Agonist In Vivo Efficacy60%

related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia60%

related🧫Vascular Contribution to Alzheimer's Disease — Beyond A60%

related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol60%

related🧫Viral Infections and Alzheimer's Disease — causal mecha60%

see_also📖TARDBP — TAR DNA Binding Protein 4360%

see_also📖proteins-tdp43_protein60%

related🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste58%

related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors57%

related🧪Vocal Cord Neuroplasticity Stimulation56%

related🔬What are the mechanisms underlying rna binding protein dysre54%

related🧫Proposed experiment from debate on Synaptic pruning by micro54%

related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%

related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%

related🧫4R-Tau Targeting Therapies for PSP and CBS54%

related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi54%

related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti54%

related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?54%

related🧫Anti-Tau Immunotherapy Dosing Optimization54%

related🧫Experiment: Autoimmune Hypothesis Testing in AD54%

related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#54%

related🧫tACS Connectivity Trial in Early Alzheimer's54%

related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%

related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 54%

related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M54%

related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera54%

related🧫Gap Junction Dysfunction Validation in Parkinson's Dise54%

related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise54%

related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech54%

related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis54%

related🧫Mixed Pathology Effects on Parkinson's Disease Progress54%

related🧫Neural Stem Cell Therapy for Alzheimer's Disease54%

related🧫Normal Aging to Alzheimer's Disease Transition Trigger 54%

related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%

related🧫Prion Strain Diversity and Selective Vulnerability54%

related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease54%

related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#54%

related🧫Sex Differences in Alzheimer's Disease — mechanisms and54%

related🧫Sleep Disruption and Alzheimer's Disease — mechanism an54%

related🧫Traumatic Brain Injury and Alzheimer's Disease Relation54%

related🧫Vascular Contribution to Alzheimer's Disease — Beyond A54%

related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol54%

related🧫Viral Infections and Alzheimer's Disease — causal mecha54%

mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%

mentions🧪VCP-Mediated Autophagy Enhancement50%

mentions🧪LRP1-Dependent Tau Uptake Disruption50%

mentions🧪Extracellular Vesicle Biogenesis Modulation50%

mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%

mentions🧪Synaptic Vesicle Tau Capture Inhibition50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%

mentions🧪Trans-Synaptic Adhesion Molecule Modulation50%

mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

mentions🧫TRIM21-mediated K63-linked ubiquitination of G3BP150%

mentions🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

mentions🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci50%

mentions🧪Arginine Methylation Enhancement Therapy50%

mentions🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar50%

mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting50%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%

mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement50%

mentions🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub50%

mentions🧪Low Complexity Domain Cross-Linking Inhibition50%

mentions🧪Glycine-Rich Domain Competitive Inhibition50%

mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

mentions🧪R-Loop Resolution Enhancement Therapy50%

mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%

mentions🧪Nucleolar Stress Response Normalization50%

mentions🧪Cross-Seeding Prevention Strategy50%

mentions🧪Liquid-Liquid Phase Separation Modifier Therapy50%

mentions🧪Sphingolipid Metabolism Reprogramming50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬Epigenetic reprogramming in aging neurons50%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

related🔬Investigate prion-like spreading of tau pathology through co50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬The disease-associated microglia (DAM) phenotype involves TR50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying protein aggregation cross50%

related🔬What are the mechanisms underlying mechanistic role of apoe 50%

related🔬Investigate how lipid raft composition (cholesterol metaboli50%

related🔬What are the mechanisms underlying sleep disruption as cause50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬The disease-associated microglia (DAM) phenotype involves TR50%

related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%

related🔬What gene expression changes in the aging mouse brain predic50%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%

related🔬Epigenetic reprogramming in aging neurons50%

related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%

related🔬What cell types are most vulnerable in Alzheimers Disease ba50%

related🔬What cell types are most vulnerable in Alzheimer's Dise50%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

related🔬Investigate prion-like spreading of tau pathology through co50%

related🔬What are the mechanisms by which tau pathology spreads throu50%

related🔬How does metabolic reprogramming (glucose metabolism shifts,50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the most promising therapeutic strategies for targe50%

related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%

related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%

related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%

related🧪APOE-Dependent Autophagy Restoration50%

mentions🧫Microtubule domain analysis in adult axons44%

mentions🧫Tau depletion effects on neuronal development in primary cul44%

mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers44%

mentions🧫Gandouling protection against brain injury in Wilson's 44%

mentions🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P44%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

mentions🔬What are the most promising therapeutic strategies for targe40%

mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%

mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%

mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%

mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%

mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%

mentions🔬What are the mechanisms underlying selective vulnerability o40%

mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp40%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%

mentions🔬What are the mechanisms underlying astrocyte reactivity subt40%

mentions🔬What are the mechanisms underlying blood-brain barrier trans40%

mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%

mentions🔬What are the mechanisms underlying apoe4 structural biology 40%

mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%

mentions🔬What are the mechanisms underlying digital biomarkers and ai40%

mentions🔬What are the mechanisms underlying senolytic therapy for age40%

mentions🔬What are the mechanisms underlying neuroinflammation resolut40%

mentions🔬What are the mechanisms underlying what are the mechanisms b40%

mentions🔬What are the mechanisms underlying mitochondrial transfer be40%

mentions🔬What are the mechanisms underlying protein aggregation cross40%

mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%

mentions🔬What are the mechanisms underlying sleep disruption as cause40%

mentions🔬What are the mechanisms underlying synaptic pruning by micro40%

mentions🔬What are the mechanisms underlying mitochondrial transfer be40%

mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%

mentions🔬What are the mechanisms underlying perivascular spaces and g40%

mentions🔬What gene expression changes in the aging mouse brain predic40%

mentions🔬What are the mechanisms by which tau pathology spreads throu40%

mentions🔬Investigate how lipid raft composition (cholesterol metaboli40%

mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%

related🧪HSP90-Tau Disaggregation Complex Enhancement40%

related🧪VCP-Mediated Autophagy Enhancement40%

related🧪Arginine Methylation Enhancement Therapy40%

related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%

related🧪LRP1-Dependent Tau Uptake Disruption40%

related🧪Extracellular Vesicle Biogenesis Modulation40%

related🧪Heat Shock Protein 70 Disaggregase Amplification40%

related🧪Prefrontal sensory gating circuit restoration via PV interne40%

related🧪Chaperone-Mediated APOE4 Refolding Enhancement40%

related🧪Sphingolipid Metabolism Reprogramming40%

related🧪Low Complexity Domain Cross-Linking Inhibition40%

related🧪Synaptic Vesicle Tau Capture Inhibition40%

related🧪Glycine-Rich Domain Competitive Inhibition40%

related🧪KDM6A-Mediated H3K27me3 Rejuvenation40%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%

related🧪TREM2-mediated microglial tau clearance enhancement40%

related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%

related🧪R-Loop Resolution Enhancement Therapy40%

related🧪Serine/Arginine-Rich Protein Kinase Modulation40%

related🧪Nucleolar Stress Response Normalization40%

related🧪Cross-Seeding Prevention Strategy40%

related🧪Trans-Synaptic Adhesion Molecule Modulation40%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di35%

related🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted35%

related🧪Sphingolipid Metabolism Reprogramming35%